Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01586689 · ClinicalTrials.gov registry record · Phase 2
Evaluating Alternative Aftercare Models for Ex-offenders
A Phase 2 study of Drug/Substance Abuse/Addiction and Alcohol Abuse/Addiction, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
- 270
- Enrollment target
- 1
- Study location
NCT01586689 is a Phase 2 study of Drug/Substance Abuse/Addiction and Alcohol Abuse/Addiction that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 270 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01586689, a Phase 2 study of Drug/Substance Abuse/Addiction and Alcohol Abuse/Addiction, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is examining the relative effects of alternative aftercare models for ex-offenders who are recovering from substance abuse/addiction. The study is a longitudinal, randomized field trial that assigns participants to one of three conditions: Oxford House, a professionally-run residential treatment facility, or a control condition that involves usual aftercare chosen by participants (which may include no treatment at all). Oxford Houses are self-run residential recovery homes based on the premise of mutual support. These homes do not involve professional treatment staff and the expenses (e.g. rent, utilities) are paid for by the residents. The hypothesis of this study is that Oxford House participants will have as good or better outcomes in terms of substance recovery, recidivism, and health in comparison to the participants who were assigned to the residential treatment facility, and better outcomes in comparison to the control group. In addition, the cost to government/tax payers will be substantially lower given that participants pay their own way.
Conditions Studied
Interventions
- BEHAVIORAL Oxford House
- BEHAVIORAL Safe Haven
- BEHAVIORAL Usual aftercare
Study Locations (1)
Illinois
- DePaul University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2006-09 |
| Est. Completion | 2013-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01586689
The ClinicalTrials.gov registry entry for NCT01586689 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Drug/Substance Abuse/Addiction appearing as the primary indexed condition, and to 3 interventions - of which Oxford House is the first listed.
NCT01586689 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01586689 about?
NCT01586689 is a clinical study titled "Evaluating Alternative Aftercare Models for Ex-offenders". This study is examining the relative effects of alternative aftercare models for ex-offenders who are recovering from substance abuse/addiction. The study is a longitudinal, randomized field trial that assigns participants to one of three conditions: Oxford House, a professionally-run residential tr...
What is the current status of trial NCT01586689?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 270 participants. The study started on 2006-09. Estimated completion is 2013-06.
What conditions does trial NCT01586689 study?
This clinical trial studies the following conditions: Drug/Substance Abuse/Addiction, Alcohol Abuse/Addiction.
What interventions are being tested in trial NCT01586689?
The interventions under investigation include: Oxford House (BEHAVIORAL), Safe Haven (BEHAVIORAL), Usual aftercare (BEHAVIORAL).
Who is sponsoring clinical trial NCT01586689?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01586689 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.